# Evidera

Evidera is an other based in Bethesda, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Bethesda, United States
- **Region:** North America
- **Address:** Bethesda, MD, United States
- **Assets under management:** Undisclosed
- **Website:** www.evidera.com

## Regulatory record

- **Reports private funds:** No

## About

Evidera operates as a business unit inside PPD, the contract research organization that Thermo Fisher Scientific acquired for $17.4B in 2021. The unit provides real-world evidence (RWE) consulting and research services to the pharmaceutical and biotech industry. Its offerings span observational studies, pregnancy and lactation studies, patient-centered research, and implementation science — all built to support drug approval and market access across the product life cycle. Evidera's team designs and executes non-interventional studies using both primary data collection and proprietary secondary data sources, including the PPD CorEvitas Registries — independent longitudinal registries that capture clinician- and patient-reported information. Work spans therapeutic areas and geographies, with clients including top global drugmakers. The unit markets to stakeholders in North America, Europe, and Asia. Services include clinical trial feasibility support, endpoint optimization, comparative effectiveness research, safety monitoring, and value-based pricing evidence. The group employs a multidisciplinary global team of scientists, epidemiologists, and data analysts. Its service model is fee-for-service project work for pharmaceutical sponsors. No public information exists on revenue, AUM, total employees, or named principals. Evidera does not operate as an investment vehicle and does not deploy capital; the firm is a service provider within its parent's broader clinical research segment. Evidera's structural differentiator is its integration into the largest standalone CRO — PPD — which gives it access to a global clinical trial infrastructure and proprietary data assets like CorEvitas Registries. This positions Evidera as an internal RWE capability rather than a standalone consultancy, allowing it to deliver evidence packages that span from pre-approval through post-market commitments.

## Sectors

- Healthcare Services

## Questions

### What services does Evidera provide?

Evidera offers observational study design, real-world data analysis, pregnancy and lactation studies, patient-centered research, and implementation science (per the firm's website). The unit helps drugmakers generate the evidence needed for regulatory approval, HTA submissions, and market access across the product lifecycle.

### Does Evidera invest in companies or manage a portfolio?

No. Evidera is a service provider, not an investor. It does not hold portfolio companies, deploy capital, or manage any investment fund. Its work consists of fee-for-service research projects for pharmaceutical and biotech sponsors.

### What data sources does Evidera use?

Evidera uses both primary data collection through new observational studies and secondary analysis of existing real-world data. A key proprietary asset is the PPD CorEvitas Registries, which capture regulatory-grade clinician- and patient-reported longitudinal data (per the firm's website).

## Related profiles

- [New England Development](https://altss.com/profile/new-england-development)
- [Magneto & Diesel Injector Service](https://altss.com/profile/magneto-and-diesel-injector-service)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/evidera

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology